Universitatsklinikum des Saarlandes

Homburg 66424

2 studies enrolling now · 7 studies all time

What they study most

Advanced Hepatocellular Carcinoma (HCC), Breast Cancer, CIDP, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy), Cardiovascular Diseases, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Chronic Kidney Diseases, Diabetes Mellitus, HER2 Positive Breast Cancer, Hypertension, Ovarian Neoplasms, PE - Pulmonary Embolism

Studies at this site

• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — Recruiting now
• Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study — Recruiting now
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed
• A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC — Stopped early
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early
• Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer — Stopped early